Introduction
Among the molecular modulators of cytoskeletal organization are the Abl family tyrosine kinases c-Abl and Arg (Abl1 and Abl2) that regulate actin dynamics by phosphorylating cytoskeletal proteins and through direct F-actin binding (Woodring et al., 2003; Hernandez et al., 2004) . In addition to a catalytic domain, they possess SH3-, SH2-and actin-binding domains (Pendergast, 2002) . c-Abl localizes to the nucleus and cytoplasm. Nuclear c-Abl has a function in transcription regulation and induction of apoptosis (Zhu and Wang, 2004) . Cytoplasmic c-Abl regulates F-actin-dependent cytoskeletal changes to affect cell adhesion, migration, pathogen infectivity, neurite outgrowth and apoptosis (Van Etten, 1999) .
The intrinsic kinase activity of c-Abl is strictly regulated through intra-and intermolecular interactions and phosphorylation of critical residues (Smith and Mayer, 2002) . SH3 domain deletion or mutation results in its activation (Brasher and Van Etten, 2000; Wang, 2004) . Phosphorylation of Y412 and Y245 of c-Abl corresponds with its activation. F-actin-binding domain (FABD) negatively regulates its activity. c-Abl is activated by physiological stimuli such as DNA damage, oxidative stress, integrin activation and growth factor stimulation (Pendergast, 2002) , but mechanisms regulating c-Abl activity are poorly understood. Overexpression of c-Abl induces apoptosis, and c-Abl null cells are more resistant to apoptotic stimuli Yuan et al., 1997; Theis and Roemer, 1998; Cong and Goff, 1999) . It functions through phosphorylation of target proteins in a context-dependent manner and integrates signals to actin remodelling (Woodring et al., 2003) . Morphological changes that occur during apoptosis, such as detachment, shrinkage and membrane blebbing, are dependent on actin cytoskeletal modification (Franklin-Tong and Gourlay, 2008) . Through phosphorylation of Crk, cytoplasmic c-Abl induces cytoskeletal disruption and cell death (Kain et al., 2003) .
C3G (RapGEF1) is an ubiquitously expressed guanine nucleotide exchange factor that targets small GTPases Rap1, Rap2, R-Ras and TC-10 (Gotoh et al., 1995 (Gotoh et al., , 1997 Mochizuki et al., 2000; Ohba et al., 2000; Chiang et al., 2006) . C3G has been implicated in pathways triggered by growth factors, cytokines, G-protein-coupled receptors and adhesion receptors. C-terminus of C3G is responsible for target G-protein activation, and proline-rich sequences in its central region bind SH3 domains of Crk, Cas, c-Abl and Hck (Knudsen et al., 1994; Tanaka et al., 1994; Kirsch et al., 1998; Shivakrupa et al., 2003; Radha et al., 2007) . The catalytic activity of C3G is regulated by Crk binding and tyrosine phosphorylation at Y504 (Ichiba et al., 1999) . Src family kinases phosphorylate C3G, and Y504-phosphorylated C3G localizes to the Golgi and subcortical actin cytoskeleton (Radha et al., 2004) . When co-expressed in mammalian cells, interaction of Hck with C3G results in activation of an apoptotic pathway, which is independent of the catalytic activity of C3G (Shivakrupa et al., 2003) . Non-catalytic sequences of C3G are responsible for suppression of transformation induced by oncogenes (Guerrero et al., 2004) . C3G has a function in cytoskeletal reorganization and filopodia formation (Radha et al., 2007) . It interacts with c-Abl and is required for c-Abl-induced filopodia formation in response to integrin stimulation. C3G is induced during neuronal differentiation and regulates survival and differentiation of human neuroblastoma cells (Radha et al., 2008) . Knockout of C3G in mice causes embryonic lethality, and mutant fibroblasts show impaired cell adhesion and enhanced cell migration (Ohba et al., 2001) .
Kinase activity of c-Abl is required not only for its transforming activity, but also for apoptosis. c-Abl levels increase under certain conditions leading to cell death (Alvarez et al., 2004) . The cytostatic effects of cAbl have been attributed to its ability to induce apoptosis. It has, therefore, been important to identify Abl activation mechanisms as well as effector substrates involved in apoptosis. Our recent finding of a direct interaction between c-Abl and C3G prompted us to investigate the ability of c-Abl to phosphorylate C3G and determine functional consequence with respect to cAbl signalling. c-Abl overexpression or activation of cellular Abl by oxidative stress resulted in phosphorylation of endogenous C3G on Y504. FABD of c-Abl regulates it to phosphorylate C3G in specific subcellular domains. We also show that C3G is an effector of c-Ablmediated cell death.
Results

c-Abl phosphorylates C3G at Y504
The possibility of C3G being a substrate of c-Abl in vivo was explored using p-C3G (pY504-C3G) antibody whose specificity to recognize C3G phosphorylated only on Y504 has been shown in immunoblotting and immunofluorescence (Shivakrupa et al., 2003; Radha et al., 2004) . Co-expression of C3G with c-Abl in Cos-1 cells showed phosphorylation of C3G at Y504 (Figure 1a ). Cells expressing C3G or c-Abl alone did not show any pY504 reactivity under these conditions. Co-expression of a phosphorylation site mutant Y504F with c-Abl failed to show any reactivity with this antibody, but showed positivity with anti-p-Tyr antibodies, suggesting that c-Abl may be causing phosphorylation of other tyrosine residues in C3G. Phosphorylation of C3G and Y504F mutant on coexpression with c-Abl was confirmed by blotting C3G immunoprecipitates using p-Tyr and p-C3G antibodies (Figure 1b) . In vitro kinase assay performed using purified recombinant GST-CBR fusion protein and Abl immunoprecipitates from cells expressing c-Abl or KDc-Abl showed phosphorylation of GST-CBR when incubated with WT-Abl but not with KD-Abl. No signal was seen on GST (Figure 1c) .
Lysates from cells transiently expressing c-Abl showed phosphorylation of endogenous C3G on longer exposure (Figure 1d ). pY504-C3G antibody does not recognize unphosphorylated C3G or Y504F mutant in situ (Supplementary Figure 1a) . On activation of cellular tyrosine kinases by pervanadate (PV), this antibody showed enhanced reactivity in cells expressing C3G, but not the Y504F mutant. In c-Abl-expressing cells, p-C3G showed restricted staining relative to total cellular p-Tyr, indicating that this antibody does not recognize other cellular-phosphorylated proteins nonspecifically (Supplementary Figure 1c) . Exogenous c-Abl showed diffuse staining throughout the cytoplasm. Surprisingly, p-C3G was observed only in about 20-25% of c-Abl-expressing cells (Figure 1d lower panel). p-C3G-positive cells showed loss of cell volume, retraction, and condensed chromatin, features characteristic of apoptosis ( Figure 1e ). No p-C3G was observed in c-Abl-expressing healthy cells showing well-spread morphology. Few cells at early stages of detachment with condensed nuclei showed polarized p-C3G staining, which did not correspond to localization of c-Abl and was restricted to phase dense membranous retractions (Figure 1e ). Ectopic expression of c-Abl has earlier been shown to induce apoptosis, and we confirmed this by counter-staining using TUNEL reagent and cleaved caspase-3 antibody ( Figure 1f) . As a marker for early apoptotic changes in cells, gH2AX (Ragakou et al., 2000) was also used to show that on c-Abl expression, p-C3G-positive cells were indeed undergoing apoptosis (Figure 1f ). Confocal sections through the z axis from the adherent surface of a c-Ablexpressing apoptotic cell (Supplementary Video 1) and 3D reconstruction using IMARIS software showed restricted pattern of p-C3G staining relative to that of c-Abl (Figure 1g ). Areas showing p-C3G did not necessarily correspond to areas of cell attachment as seen from a view of the adherent surface after isosurface rendering. Similar results were obtained in HEK293 or HeLa cells transfected with c-Abl.
c-Abl induced cell death scored by pH2B(S14) positivity, an early marker for cell death (Cheung et al., 2003) -matched quantitation of apoptosis scored using morphological criteria ( Supplementary Figures 2a  and b) . Staurosporine treatment enhanced apoptosis in c-Abl-expressing cells concomitant with an increase in the number of p-C3G-stained cells and an increase in p-C3G and p-Abl levels ( Supplementary Figures 2c and  d) . Inhibition of cell death induced by c-Abl using a pan-caspase inhibitor, ZVAD-FMK, reduced p-C3G and p-Abl levels ( Supplementary Figure 2e) , indicating correlation of c-Abl-induced pY504-C3G with its ability to induce cell death. Cell retraction is a feature of cells undergoing cell death as well as cell division. Neither c-Abl expressing nor non-expressing cells undergoing mitosis showed any p-C3G (Supplementary Figure 3a) . c-Abl-expressing cells induced to retract because of junctional breakdown on EDTA treatment showed no p-C3G (Supplementary Figure 3b) , indicating that phosphorylation of C3G by c-Abl is specifically associated with apoptosis.
C3G is a target and effector of c-Abl function A Mitra and V Radha C3G phosphorylation is dependent on restricted c-Abl activation Restricted C3G phosphorylation in c-Abl-expressing cells may be due to localized substrate availability or localized enzyme activation. In cells expressing C3G and c-Abl, C3G localized throughout the cytoplasm, but p-C3G still showed a polarized and restricted pattern (Figure 2a) . Most of the cytoplasmic C3G was not phosphorylated. pY245 staining, an indicator of c-Abl activation, was present only in a fraction of c-Ablexpressing cells with apoptotic morphology (Figure 2b ). pY245 staining was polarized and did not match c-Abl localization though c-Abl seemed to be more concentrated in these areas. Fluorescence intensity quantitation profiles confirmed the presence of p-C3G and p-Abl in restricted locations within cells (Figure 2c) . No significant change in activated c-Abl was found when coexpressed with C3G (Figure 2d ). These results indicate that overexpressed C3G does not activate c-Abl. CrkII adaptor is a substrate and regulator of c-Abl. CrkII-C3G is a target and effector of c-Abl function A Mitra and V Radha Y221 when phosphorylated by c-Abl inhibits cell migration and promotes apoptosis (Holcomb et al., 2006; Cipres et al., 2007) . pY221-Crk staining in c-Ablexpressing cells showed a pattern similar to that of p-Abl (Figure 2e ). These results suggest that localized p-C3G staining is due to localized activation of c-Abl and not because of localized substrate availability. Crk-II co-expression reduced pY504-C3G levels, which was also reflected in a decrease in c-Abl activation (Supplementary Figure 4a ). An N-terminal SH3 mutant (W170K) compromised for interaction with c-Abl as well as C3G also reduced c-Abl activation. Under these conditions, WT as well as Crk mutant are phosphorylated on Y221. Reduction in pY504-C3G on expression of CrkII or W170K was also reflected in reduction in apoptosis induced by c-Abl (Supplementary Figure 4b) .
Y504 phosphorylation of C3G enhances its activity towards Rap1. GFP-RalGDS-RBD protein used to monitor Rap1 activation (Bivona et al., 2004) is normally distributed throughout the nucleus and cytoplasm. In areas positive for p-C3G, GFP-RalGDS-RBD was particularly intense in those areas relative to the rest of the cell indicating restricted activation of Rap1 ( Figure 2f ).
C3G phosphorylation is dependent on catalytic activity of c-Abl, as constitutively active DXB enhanced pY504-C3G relative to WT c-Abl, whereas catalytically inactive c-Abl showed no pY504-C3G (Figures 3a and b) . C3G showed weak phosphorylation in cells expressing WT c-Abl compared with cells expressing Hck. In situ, DXB and KD-Abl showed similar subcellular localization to that of WT c-Abl (Figure 3c ). Although no p-C3G is seen in either live or dead cells expressing KD-Abl, p-C3G was distributed throughout the cytoplasm and in all cells expressing DXB. Similar patterns were seen for p-Abl (data not shown). Unlike c-Abl, expression of Hck showed p-C3G in all expressing cells that matched localization of Hck. These findings suggested that activity of exogenously expressed WT c-Abl is repressed in healthy cells and its activation coincides with induction of morphological changes leading to apoptosis. On treatment of c-Abl-expressing cells with 50 mM sodium orthovanadate (an inhibitor of tyrosine phosphatases) for 4 h before fixation, all expressing cells showed p-C3G and p-Abl staining (Supplementary Figure 5) .
Activation of endogenous c-Abl by oxidative stress results in C3G phosphorylation
Phosphorylation of C3G in response to H 2 O 2 or PV, known activators of endogenous c-Abl (Woodring et al., 2003) , was examined. H 2 O 2 treatment activated ectopically expressed c-Abl to phosphorylate cellular C3G dependent on c-Abl activity (Figure 4a ). Untransfected Cos-1 cells treated with H 2 O 2 or PV also showed that pY504-C3G was partially inhibited by STI571 ( Figures  4b and c) . STI-sensitive cellular kinases contribute to >50% of C3G phosphorylation in response to H 2 O 2 and PV, but contribute minimally to PV-induced cellular p-Tyr. STI571 treatment alone did not effect cell survival or phosphorylation of endogenous proteins. In situ examination showed pY504-C3G in all c-Ablexpressing cells in response to H 2 O 2 (Supplementary Figure 6 ). Cells expressing KD-Abl showed no p-C3G in the presence or absence of H 2 O 2 , suggesting that kinase activity of Abl was responsible for H 2 O 2 -inducedenhanced C3G phosphorylation. PV treatment, which can activate a variety of cellular tyrosine kinases resulted in phosphorylation of C3G throughout the cytoplasm. Expression of KD-Abl showed repression of C3G phosphorylation by functioning as a dominant negative ( Figure 4d ). Collectively, this data suggested that endogenous c-Abl activation is associated with Y504C3G phosphorylation. Integrin engagement is known to transiently activate c-Abl. No enhancement in p-C3G staining in c-Abl-expressing cells during attachment and spreading on fibronectin was seen (data not shown).
Subcellular localization of p-C3G is dependent on F-actin dynamics c-Abl distributes to areas of F-actin concentration and can bundle actin filaments (Van Etten et al., 1994) . c-Abl-expressing cells stained for p-C3G and F-actin showed p-C3G co-localizing with areas of high F-actin intensity in apoptotic cells (Figure 5a ). c-Abl too showed higher intensity in F-actin-rich regions. Cyto- C3G is a target and effector of c-Abl function A Mitra and V Radha chalasinD-treated c-Abl-expressing cells showed loss of polarized p-C3G staining concomitant with a loss of F-actin organization (Figure 5b ). Weak staining was seen in rounded cells. Jasplakinolide treatment, which stabilizes F-actin, showed p-C3G staining throughout the cytoplasm in cells with condensed chromatin and signs of retraction (Figure 5c ). Jasplakinolide did not result in phosphorylation of C3G in healthy c-Ablexpressing cells. p-Abl was also seen throughout c-Abl-expressing cells with condensed chromatin on jasplakinolide treatment (data not shown). F-actin-rich regions in which p-C3G localized were weak in tubulin staining, indicating that they are contractile regions rather than cellular extensions (Figure 5d ). On treatment with nocodazole, neither the intensity nor the localization pattern of p-C3G was affected. Quantitation of fluorescence showed that polymerized tubulin was conspicuously absent in regions of p-C3G staining, but in nocodazole-treated cells, tubulin was present diffused throughout the cells (Figure 5d ). c-Abl-mediated Y504 phosphorylation is, therefore, dependent on actin and not microtubule dynamics. 
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Our studies suggested that p-C3G may be interacting with F-actin. By examining resistance to detergent extraction, an approach that enables in situ examination of actin binding (Janji et al., 2006) , we observed c-Abl extractability, but retention of p-C3G in F-actin dense structures (Figure 6a ). In cells co-expressing C3G and c-Abl, C3G was extractable, whereas p-C3G was retained (Figure 6b ). Some staining for both c-Abl and C3G was seen in areas with p-C3G, indicating that a small fraction of these proteins may be retained with F-actin. Jasplakinolide-treated cells showed enhanced retention of c-Abl as well as p-C3G on detergent extraction, suggesting that detergent resistance was essentially due to their association with F-actin (Figure 6a ).
Polarized C3G phosphorylation and induction of apoptosis by c-Abl are dependent on its FABD A deletion construct lacking amino acids responsible for F-actin binding showed higher activity relative to c-Abl, and DXB, when probed for p-Abl, but weak pY504-C3G (Figures 7a and b) . In situ, p-C3G was present in juxtanuclear vesicular structures in which DFABD was more concentrated, and was not restricted to apoptotic cells as in the case of WT c-Abl (Figure 7c) . No co-localization with F-actin was seen (Figure 7d ). Active c-Abl was also seen in juxtanuclear vesicles in cells expressing DFABD (Supplementary Figure 7) .
Ability of c-Abl to induce apoptosis is regulated by various domains (Theis and Roemer, 1998) . As c-Abl constructs showed differences in ability to phosphorylate C3G, we determined whether their ability to induce apoptosis correlates with their ability to phosphorylate C3G. A time-dependent increase in apoptosis is seen on expression of c-Abl and DXB constructs. At 30, 36 and 42 h after transfection, c-Abl induces 20.15, 27.63 and 29.5% cell death in expressing cells, whereas DXB shows 28.53, 44.72 and 44.1% cell death. The extent of apoptosis was comparable with that seen in earlier studies. At 30 h of expression, c-Abl showed a good correlation between p-C3G positive and apoptotic cells (Figure 7e ). Similar correlation was seen between p-Abl positive and apoptotic cells (data not shown).
KD-Abl as well as DFABD induced very low levels of apoptosis, even though p-C3G was seen in vescicles in about 50% of cells expressing DFABD. DXB expression 
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A Mitra and V Radha showed p-C3G in nearly all expressing cells and also enhanced apoptosis relative to WT. These results showed that restricted activation and phosphorylation of C3G by c-Abl is dependent on SH3 and FAB domains, and correlation of p-C3G staining with induction of apoptosis is lost on deletion of these domains.
c-Abl-mediated apoptosis is dependent on C3G
Coincidence of C3G phosphorylation with apoptosis prompted us to investigate whether c-Abl-induced apoptosis was dependent on C3G function. Co-expressing an shRNA vector that reduces endogenous C3G protein level (Figure 8a ) along with c-Abl resulted in inhibition of c-Abl-induced apoptosis by 48% (Figure 8b) . A deletion construct of C3G (CBR), which dominantly inhibits endogenous C3G-dependent signalling (Radha et al., 2008) , reduced c-Abl as well as DXB-induced apoptosis (Figures 8d and e) . Co-expression of CBR did not affect expression levels of c-Abl (Figure 8c) . Similarly, in MCF-7 cells, co-expression of CBR reduced c-Abl-induced cell death from 25.2 to 8.5%. As Rap1 activation was observed only in apoptotic c-Abl-expressing cells, we tested the requirement of Rap1 activation for c-Abl-induced cell death. Inhibition of Rap1 activation in c-Abl-expressing cells by co-expression of GFPRap1GAP resulted in reduced apoptosis (Figure 8f ). H 2 O 2 induces cell death dependent on c-Abl (Sun et al., 2000) . Expression of WT C3G resulted in a significant increase in H 2 O 2 -induced apoptosis, but Y504F mutant, which inhibits signalling dependent on Y504 phosphorylation, reduced apoptosis by 59% (Figures 8g and h) . Ability of H 2 O 2 to induce cell death was confirmed by TUNEL staining (Supplementary Figure 8a) . WT C3G-expressing apoptotic cells were positive for p-C3G, whereas no p-C3G was seen on expression of Y504F mutant (Supplementary Figure 8b) . 
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Discussion
The cellular Abelson tyrosine kinase is a multifunctional protein having functions in apoptosis and actin remodelling to affect morphological changes in cells. Apoptosis involves major cytoskeletal reorganization, and we provide evidence that c-Abl is specifically activated to phosphorylate C3G, on Y504, to induce cell death. Phosphorylation of C3G is dependent on kinase activity of c-Abl as shown through in vitro kinase assays, in vivo phosphorylation and indirect immunofluorescence experiments. C3G has been implicated in Bcr-Abl-mediated signalling (Maia et al., 2009 ). Bcr-Abl-mediated tyrosine phosphorylation of C3G, detected by p-Tyr antibodies was dependent on CrkL co-expression in Cos cells (Cho et al., 2005) , but we observed reduction in c-Abl activity and pY504-C3G on CrkII co-expression.
In Bcr-Abl-expressing leukaemic cells, phosphorylation was seen on p87C3G, a splice variant and not on fulllength C3G (Gutierrez-Berzal et al., 2006) . Our results implicate differences in c-Abl and Bcr-Abl to engage and phosphorylate C3G. C3G is also phosphorylated by endogenous c-Abl on activation by H 2 O 2 and PV. This study shows that Y504 of C3G is targeted by c-Abl in addition to being a substrate of SFKs (Shivakrupa et al., 2003; Radha et al., 2004) . Apart from Y504, c-Abl can phosphorylate other tyrosine residues on C3G, and their physiological relevance is pending investigation. Many studies including this study have described the lack of constitutive activity in exogenously expressed c-Abl. Multiple lines of evidence indicate that c-Abl activation and restricted C3G phosphorylation coincide with apoptosis: (1) cells positive for p-C3G stain positive 
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A Mitra and V Radha for apoptotic markers such as TUNEL and g-H2AX; (2) enhanced p-Abl and p-C3G levels in c-Abl-expressing cells treated with staurosporine correspond with enhanced apoptosis; (3) Z-VAD, a caspase inhibitor known to reduce c-Abl-induced cell death causes reduction in p-C3G and p-Abl levels; (4) co-expression of CrkII with c-Abl results in reduction of p-C3G/p-Abl levels, which correspond with a reduction in cell death and (5) Y504C3G phosphorylation is only associated with apoptosis and not with cells undergoing retraction during mitosis or junctional breakdown. Coincidence of C3G phosphorylation with cell death is lost in cells expressing Abl constructs lacking SH3 and FAB domains, indicating the function of these domains in regulating c-Abl activity and function. In c-Abl-expressing cells, p-C3G staining was seen in areas of intense F-actin localization that seemed to correspond to retracting lamellipodia. As shown earlier (Ba et al., 2005) , we also observed that c-Abl distributes to areas of high F-actin concentration. Localized p-C3G staining was due to localized activation of c-Abl and not because of restricted substrate availability. Cellular tyrosine phosphatases may be responsible for restricting c-Abl activity, as vanadate exposure resulted in activation of c-Abl in all expressing cells. Reciprocal regulation, whereby a substrate interacts with and activates C3G is a target and effector of c-Abl function A Mitra and V Radha c-Abl to phosphorylate itself is known in the case of Abl targets (Shishido et al., 2001; Hu et al., 2005) , but C3G co-expression did not alter c-Abl activity. Phosphorylation of another c-Abl substrate, CrkII, also occurred only in cells showing detachment and condensed chromatin. CrkII contributes to cell detachment during apoptosis (Lawrenson et al., 2002 ). An earlier study has reported activation of c-Abl in apoptotic cells 
A Mitra and V Radha (Machuy et al., 2004 ), but we show for the first time its localized activation to phosphorylate CrkII as well as a novel substrate, C3G. Some of the mechanisms involved in detachment of apoptotic cells are common to those controlling tail retraction during polarized migration. BCR-Abl and some of its target proteins showed polarized distribution, co-localizing with F-actin at trailing portions of migratory 32D cells (Skourides et al., 1999) . Organized actin is an essential prerequisite for cell constriction and c-Abl regulates polarized actin accumulation by downregulation of Ena (Grevengoed et al., 2003) . In vivo, c-Abl overexpression resulted in its localized activation in the apical cell cluster with a pool of inactive Abl in the cytoplasm, suggesting that restricted Abl activation is a mechanism for effecting localized cytoskeletal changes (Stevens et al., 2008) . Our study shows that C3G phosphorylation mediated by WT c-Abl is associated with apoptosis, but not with retraction seen in cells undergoing mitosis or junctional breakdown indicating that specific molecular events are associated with cell retraction under different conditions. The absence of p-C3G staining in c-Abl-expressing cells plated on fibronectin indicated that molecular events leading to extending lamellipodia and filopodia differ from those occurring during cell retraction in apoptotic cells.
Presence of p-C3G and activated Rap1 in F-actin-rich domains implies their function in affecting cytoskeleton changes. This was confirmed by showing requirement of Rap1 activation for induction of cell death by c-Abl. Rap1 upregulation is required for apoptosis induced by histone deacetylase inhibition (Kobayashi et al., 2006) and Rap1 activity increases on cell detachment from substratum (Balzac et al., 2005) . C3G is activated in response to mechanical stress signals involving cytoskeletal stretch (Tamada et al., 2004) , and has recently been shown to bind actin through its proline-rich domain (Martin-Encabo et al., 2007) . Our results suggest that phosphorylation of tyrosine within this domain may enhance its ability to interact with F-actin, which is present in highly polymerized form in some c-Ablexpressing cells. This may, therefore, enable forming a platform for localized Rap1 activation required for inducing morphological changes during apoptosis. This is also consistent with our results, which showed that p-C3G staining correlates with apoptosis on WT c-Abl expression, and functional inactivation of C3G inhibits c-Abl-induced apoptosis. Cell detachment in HEK293 cells expressing constitutively active Abl required Rho activation and Rap1 inactivation (Huang et al., 2008a) . In T-cells, Abl regulates T-cell receptor-stimulated Rap1 activation (Nolz et al., 2008) . Abl can, therefore, activate as well as repress Rap1 depending on the cell type and stimulus.
Disruption of actin dynamics or deletion of FABD affected the polarized activation of c-Abl to phosphorylate C3G, providing evidence that an intact cytoskeleton, along with c-Abl's ability to bind F-actin, is important for regulation of c-Abl activity. C3G, when phosphorylated by DFABD Abl showed punctate staining in juxtanuclear regions of the cell.
No correlation is seen with cells undergoing cell death. In Saos2 cells, kinase-defective c-Abl was partially competent in inducing cell death, whereas a catalytically active variant lacking the C-terminal 105 residues was unable to cause apoptosis (Theis and Roemer, 1998) . Factin binding is, therefore, an essential requisite for overexpressed c-Abl to induce cell death.
In the context of cells overexpressing c-Abl, it is not definitively known what triggers its localized activation. PTP-PEST localizes to membrane ruffles and retracting lamellipodia in apoptotic cells, and cleavage of PTP-PEST contributes to cellular detachment during apoptosis (Halle et al., 2007) . As PTP-PEST negatively regulates c-Abl activity (Cong et al., 2000) , it is possible that its degradation results in Abl activation. As localized Abl activation is dependent on an intact cytoskeleton and on the FABD of c-Abl, we suggest that F-actin binding regulates c-Abl activation. It is known that reciprocal relationship exists with respect to c-Abl and F-actin interactions, in which the kinase can remodel actin, and F-actin can regulate c-Abl's ability to phosphorylate specific target proteins (Woodring et al., 2001 (Woodring et al., , 2005 . In stimulated neutrophils, c-Abl activity increases concomitant with an increase in F-actin concentration (Chen et al., 2006) and c-Abl regulates actin remodelling at immune synapse (Huang et al., 2008b) . It is possible that in vivo, the intramolecular interactions between FABD and other regions of c-Abl are relieved by its deletion or through its interaction with F-actin. Our experiments showing c-Abl activation only in regions of cells with F-actin aggregates suggest that in the cellular context, F-actin binding may be responsible for restricted activation of c-Abl, or F-actinrich domains may serve to release c-Abl autoinhibition. It is also possible that association with F-actin aids interaction between c-Abl and an unidentified activator to phosphorylate C3G locally. That cellular factors are responsible for modulating c-Abl activity is evident from our results showing that c-Abl immunoprecipitated from cell lysates phosphorylates C3G in vitro, whereas purified c-Abl is unable to do so (Nolz et al., 2008) . F-actin-rich domains in the cell may, therefore, serve as platforms to bring together c-Abl and its target proteins. These results are consistent with a model whereby overexpressed c-Abl induces localized actin bundling dependent on its FABD. These areas serve as a platform for c-Abl activation leading to C3G phosphorylation. C3G-dependent functions such as Rap1 activation may trigger signalling pathways causing cell death.
Apoptosis inducing function was earlier described as a property of nuclear c-Abl (Zhu and Wang, 2004) . More recently, it has been reported that c-Abl activation induces the phosphorylation of Crk in the cytoplasmic compartment (Holcomb et al., 2006) . H 2 O 2 is known to selectively activate cytoplasmic, but not nuclear Abl (Sun et al., 2000) . Our results suggested that cytoplasmic Abl is responsible for phosphorylation of C3G and induction of apoptotic changes. Using RNAi-mediated knockdown and dominant-negative approach, we showed that C3G contributes to c-Abl-and H 2 O 2 -induced cell death. C3G and CrkII are, therefore, two cytoplasmic targets of c-Abl involved in Abl-mediated apoptosis.
Our results, therefore, identify C3G as a novel substrate of c-Abl, which shows selective and polarized activation at F-actin-rich compartments to induce apoptosis. FABD-dependent localized phosphorylation of C3G correlates with the ability of c-Abl to induce cell death. C3G is phosphorylated in a c-Abl-dependent manner in response to oxidative stress and is involved in mediating apoptosis. In addition to its kinase activity, functions mediated through F-actin binding are, therefore, important in regulating c-Abl to phosphorylate C3G and to induce apoptosis.
Materials and methods
Expression constructs
Plasmids encoding C3G and various mutants have been described (Radha et al., 2007) . GFP-RalGDS-RBD construct was gifted by Dr PJS Stork. Human c-Abl expression vector c-Abl-pSGT, constitutively active c-Abl mutant (DXB-with deleted SH3 domain) and catalytically inactive c-Abl construct (K290M/KD-Abl) were from Dr Richard Van Etten. Hck cDNA cloned into pCDNA6 was from Dr Todd Miller. GFPRap1GAP construct was from Dr Patrick Casey. CrkII and W170K mutant were gifted by Dr Bruce Mayer. The GST-CBR construct containing Y504 was generated by sub-cloning human C3G Crk-binding region fragment into pGEX-5X2. Vectors for shRNA expression to target human C3G (ShC and mShC) have been described earlier (Radha et al., 2007) . c-Abl with deletion of its actin-binding domain (DFABD) was generated by inserting a stop codon after amino-acid 1119 at C-terminal of c-Abl-pSGT construct. This protein lacks ability to bind F-actin (Woodring et al., 2001) .
Indirect immunofluorescence, confocal microscopy and apoptosis assays Indirect immunostaining and microscopy was carried out as described (Radha et al., 2004) . Secondary antibodies used were rabbit or mouse IgG coupled with either Cy3 (Amersham, GE Healthcare, Buckinghamshire, UK), Alexa 488 or Alexa 633 (Molecular Probes, Invitrogen, Paisley, Scotland, UK). F-actin was detected using Rhodamine or Oregon green phalloidin.
Digital images were captured either with the LSM 510 Meta Confocal Microscope (Carl Zeiss, Jena, Germany), Leica TCS SP5 confocal microscope (Leica Microsystems, Mannheim, Germany) or with a Zeiss Axioplan2 microscope fitted with an Apotome. Similar parameters of image capture were used for analysis of coverslips belonging to a particular experiment. Imaris software package (BitPlane, Switzerland) was used to reconstruct 3D images from the stacks of confocal images.
Quantitative analysis of apoptotic cells was carried out as described earlier (Radha et al., 1999; Shivakrupa et al., 2003; Subhash et al., 2006) . Cells grown on coverslips were transfected and processed for immunostaining using appropriate antibodies for detection of expressing cells and mounted with DAPI. Using a Â 40 objective of a fluorescence microscope cells that showed loss of refractility, condensed chromatin, apoptotic bodies and cell shrinkage were scored as apoptotic. This method has been used to quantitate apoptosis induced by c-Abl (Agami et al., 1999) . At least 200 expressing cells were counted in each coverslip. Background apoptosis was determined by counting non-expressing cells in the same coverslips. Data represent mean ± s.d. from at least three independent experiments on duplicate coverslips after background substraction. TUNEL assay was carried out as described earlier (Shivakrupa et al., 2003) .
